TY - JOUR AU - Ubben, David AU - Poll, Elizabeth M. PY - 2013 DA - 2013/06/19 TI - MMV in partnership: the Eurartesim® experience JO - Malaria Journal SP - 211 VL - 12 IS - 1 AB - This case study describes how a public-private partnership between Medicinesfor Malaria Venture (MMV) and Sigma-Tau Industrie Farmaceutiche Riunite SpAachieved international regulatory approval for use of the fixed-doseartemisinin-based combination therapy dihydroartemisinin-piperaquine(Eurartesim®) for the treatment of malaria, enablingmore widespread access to the medicine in malaria-endemic countries. SN - 1475-2875 UR - https://doi.org/10.1186/1475-2875-12-211 DO - 10.1186/1475-2875-12-211 ID - Ubben2013 ER -